Related Experiment Video
Updated: Jun 11, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Progression model tissue microarray (TMA) for the study of uterine carcinomas
Mohammad Arafa1, Jacques Boniver, Philippe Delvenne
1Department of Pathology, Mansoura University, Egypt.
Disease Markers
|July 2, 2010
Summary
Accurate diagnostic tools are crucial for cervical and endometrial cancers. Tissue microarray (TMA) technology aids in analyzing molecular targets within preneoplastic lesions and carcinomas, improving cancer diagnostics.
Area of Science:
- Oncology
- Molecular Pathology
- Cancer Research
Background:
- Cervical and endometrial uterine carcinomas are complex cancers.
- Preneoplastic lesions precede these uterine cancers.
- Improved diagnostic tools and molecular markers are needed for better patient outcomes.
Purpose of the Study:
- To review tissue microarray (TMA) technology.
- To highlight TMA's advantages in analyzing molecular targets.
- To consider TMA within a uterine carcinogenesis model.
Main Methods:
- Review of tissue microarray (TMA) technology.
- Application of high throughput technologies for molecular target validation.
- Morphological control of analyzed tissue fragments using TMA.
Main Results:
- Tissue microarray (TMA) allows for morphological control of tissue analysis.
- TMA is a valuable tool for high throughput testing of molecular targets.
- The technology is applicable to preneoplastic lesions and cancer.
Conclusions:
- Tissue microarray (TMA) technology is advantageous for cancer research.
- TMA facilitates the study of molecular targets in uterine carcinogenesis.
- Accurate diagnostic tools are essential for improving cancer diagnosis and treatment.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...